Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection

Trypanosoma cruzi, the aetiological agent of Chagas disease, has a highly efficient detoxification system to deal with the oxidative burst imposed by its host. One of the antioxidant enzymes involved is the cytosolic tryparedoxin peroxidase (c-TXNPx), which catalyses the reduction to hydrogen peroxi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2018
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00192805_v155_n3_p367_Girard
http://hdl.handle.net/20.500.12110/paper_00192805_v155_n3_p367_Girard
Aporte de:
id paper:paper_00192805_v155_n3_p367_Girard
record_format dspace
spelling paper:paper_00192805_v155_n3_p367_Girard2023-06-08T14:40:17Z Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection B-cell epitope prediction chronic Chagas disease peroxiredoxin T-cell and B-cell response B lymphocyte antigen CD19 antigen CD4 antigen CD69 antigen CD8 antigen cytosolic tryparedoxin peroxidase gamma interferon granulocyte macrophage colony stimulating factor HLA DR antigen immunoglobulin G interleukin 10 peroxidase unclassified drug immunoglobulin G peroxidase protozoal protein protozoon antibody tryparedoxin peroxidase adaptive immunity adult antibody titer antigen expression Article asymptomatic infection cardiac patient cell proliferation cellular immunity Chagas disease clinical article comparative study controlled study cytokine release cytosol enzyme activity evaluation study female human human cell human tissue humoral immunity immunogenicity immunoglobulin blood level macrophage male priority journal adaptive immunity aged Chagas disease clinical trial immunology middle aged pathology Trypanosoma cruzi Adaptive Immunity Adult Aged Antibodies, Protozoan Chagas Disease Female Humans Immunoglobulin G Male Middle Aged Peroxidases Protozoan Proteins Trypanosoma cruzi Trypanosoma cruzi, the aetiological agent of Chagas disease, has a highly efficient detoxification system to deal with the oxidative burst imposed by its host. One of the antioxidant enzymes involved is the cytosolic tryparedoxin peroxidase (c-TXNPx), which catalyses the reduction to hydrogen peroxide, small-chain organic hydroperoxides and peroxynitrite. This enzyme is present in all parasite stages, and its overexpression renders parasites more resistant to the oxidative defences of macrophages, favouring parasite survival. This work addressed the study of the specific humoral and cellular immune response triggered by c-TXNPx in human natural infection. Thus, sera and peripheral blood mononuclear cells (PBMC) were collected from chronically infected asymptomatic and cardiac patients, and non-infected individuals. Results showed that levels of IgG antibodies against c-TXNPx were low in sera from individuals across all groups. B-cell epitope prediction limited immunogenicity to a few, small regions on the c-TXNPx sequence. At a cellular level, PBMC from asymptomatic and cardiac patients proliferated and secreted interferon-γ after c-TXNPx stimulation, compared with mock control. However, only proliferation was higher in asymptomatic patients compared with cardiac and non-infected individuals. Furthermore, asymptomatic patients showed an enhanced frequency of CD19 + CD69 + cells upon exposure to c-TXNPx. Overall, our results show that c-TXNPx fails to induce a strong immune response in natural infection, being measurable only in those patients without any clinical symptoms. The low impact of c-TXNPx in the human immune response could be strategic for parasite survival, as it keeps this crucial antioxidant enzyme activity safe from the mechanisms of adaptive immune response. © 2018 John Wiley & Sons Ltd 2018 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00192805_v155_n3_p367_Girard http://hdl.handle.net/20.500.12110/paper_00192805_v155_n3_p367_Girard
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic B-cell epitope prediction
chronic Chagas disease
peroxiredoxin
T-cell and B-cell response
B lymphocyte antigen
CD19 antigen
CD4 antigen
CD69 antigen
CD8 antigen
cytosolic tryparedoxin peroxidase
gamma interferon
granulocyte macrophage colony stimulating factor
HLA DR antigen
immunoglobulin G
interleukin 10
peroxidase
unclassified drug
immunoglobulin G
peroxidase
protozoal protein
protozoon antibody
tryparedoxin peroxidase
adaptive immunity
adult
antibody titer
antigen expression
Article
asymptomatic infection
cardiac patient
cell proliferation
cellular immunity
Chagas disease
clinical article
comparative study
controlled study
cytokine release
cytosol
enzyme activity
evaluation study
female
human
human cell
human tissue
humoral immunity
immunogenicity
immunoglobulin blood level
macrophage
male
priority journal
adaptive immunity
aged
Chagas disease
clinical trial
immunology
middle aged
pathology
Trypanosoma cruzi
Adaptive Immunity
Adult
Aged
Antibodies, Protozoan
Chagas Disease
Female
Humans
Immunoglobulin G
Male
Middle Aged
Peroxidases
Protozoan Proteins
Trypanosoma cruzi
spellingShingle B-cell epitope prediction
chronic Chagas disease
peroxiredoxin
T-cell and B-cell response
B lymphocyte antigen
CD19 antigen
CD4 antigen
CD69 antigen
CD8 antigen
cytosolic tryparedoxin peroxidase
gamma interferon
granulocyte macrophage colony stimulating factor
HLA DR antigen
immunoglobulin G
interleukin 10
peroxidase
unclassified drug
immunoglobulin G
peroxidase
protozoal protein
protozoon antibody
tryparedoxin peroxidase
adaptive immunity
adult
antibody titer
antigen expression
Article
asymptomatic infection
cardiac patient
cell proliferation
cellular immunity
Chagas disease
clinical article
comparative study
controlled study
cytokine release
cytosol
enzyme activity
evaluation study
female
human
human cell
human tissue
humoral immunity
immunogenicity
immunoglobulin blood level
macrophage
male
priority journal
adaptive immunity
aged
Chagas disease
clinical trial
immunology
middle aged
pathology
Trypanosoma cruzi
Adaptive Immunity
Adult
Aged
Antibodies, Protozoan
Chagas Disease
Female
Humans
Immunoglobulin G
Male
Middle Aged
Peroxidases
Protozoan Proteins
Trypanosoma cruzi
Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection
topic_facet B-cell epitope prediction
chronic Chagas disease
peroxiredoxin
T-cell and B-cell response
B lymphocyte antigen
CD19 antigen
CD4 antigen
CD69 antigen
CD8 antigen
cytosolic tryparedoxin peroxidase
gamma interferon
granulocyte macrophage colony stimulating factor
HLA DR antigen
immunoglobulin G
interleukin 10
peroxidase
unclassified drug
immunoglobulin G
peroxidase
protozoal protein
protozoon antibody
tryparedoxin peroxidase
adaptive immunity
adult
antibody titer
antigen expression
Article
asymptomatic infection
cardiac patient
cell proliferation
cellular immunity
Chagas disease
clinical article
comparative study
controlled study
cytokine release
cytosol
enzyme activity
evaluation study
female
human
human cell
human tissue
humoral immunity
immunogenicity
immunoglobulin blood level
macrophage
male
priority journal
adaptive immunity
aged
Chagas disease
clinical trial
immunology
middle aged
pathology
Trypanosoma cruzi
Adaptive Immunity
Adult
Aged
Antibodies, Protozoan
Chagas Disease
Female
Humans
Immunoglobulin G
Male
Middle Aged
Peroxidases
Protozoan Proteins
Trypanosoma cruzi
description Trypanosoma cruzi, the aetiological agent of Chagas disease, has a highly efficient detoxification system to deal with the oxidative burst imposed by its host. One of the antioxidant enzymes involved is the cytosolic tryparedoxin peroxidase (c-TXNPx), which catalyses the reduction to hydrogen peroxide, small-chain organic hydroperoxides and peroxynitrite. This enzyme is present in all parasite stages, and its overexpression renders parasites more resistant to the oxidative defences of macrophages, favouring parasite survival. This work addressed the study of the specific humoral and cellular immune response triggered by c-TXNPx in human natural infection. Thus, sera and peripheral blood mononuclear cells (PBMC) were collected from chronically infected asymptomatic and cardiac patients, and non-infected individuals. Results showed that levels of IgG antibodies against c-TXNPx were low in sera from individuals across all groups. B-cell epitope prediction limited immunogenicity to a few, small regions on the c-TXNPx sequence. At a cellular level, PBMC from asymptomatic and cardiac patients proliferated and secreted interferon-γ after c-TXNPx stimulation, compared with mock control. However, only proliferation was higher in asymptomatic patients compared with cardiac and non-infected individuals. Furthermore, asymptomatic patients showed an enhanced frequency of CD19 + CD69 + cells upon exposure to c-TXNPx. Overall, our results show that c-TXNPx fails to induce a strong immune response in natural infection, being measurable only in those patients without any clinical symptoms. The low impact of c-TXNPx in the human immune response could be strategic for parasite survival, as it keeps this crucial antioxidant enzyme activity safe from the mechanisms of adaptive immune response. © 2018 John Wiley & Sons Ltd
title Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection
title_short Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection
title_full Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection
title_fullStr Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection
title_full_unstemmed Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection
title_sort evaluation of the immune response against trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection
publishDate 2018
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00192805_v155_n3_p367_Girard
http://hdl.handle.net/20.500.12110/paper_00192805_v155_n3_p367_Girard
_version_ 1768542970308460544